Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
GlaxoSmithKline
Age
18–50
Sex
ALL
Healthy volunteers
Accepted
You may be eligible if
Body Mass Index (BMI): Body Mass Index must be in the range 19-28 kg/m2.
You may not be if
Disease: Current or recurrent disease that could affect the action, absorption, elimination or disposition of the study medication or clinical or laboratory assessments (e.g. hepatic disorders evidenced by abnormal liver function test, hepatitis serology test and liver image studies, renal insufficiency, congestive heart failure).
Current or relevant previous history of serious, severe or unstable physical or psychiatric illness, any medical disorder that may require treatment or make the participant unlikely to fully complete the study, or any condition that presents undue risk from the study medication or procedures.
Clareo Health | A Pharmacokinetic Study to Compare Sustained Release and Standard Paracetamol Formulations.
